Relationship between gene polymorphism of estrogen receptor-α and endometriosis

article OA: closed CC0
View on OpenAlex
AI-generated summary by gemini-2.5-flash-lite, 2026-06-13

This study investigated estrogen receptor-α gene polymorphisms in endometriosis patients and found the Intron 1 variant genotype and P allele are associated with a reduced risk of developing endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Objective To explore relationship between intron 1 and codon 10 single nucleotide polymorphisms(SNPs) of estrogen receptor-α(ER-α)and clinical characteristics of endometriosis(EMs).Methods Different SNPs genotypes of ER-α of 78 patients with endometriosis and 81 normal control women were detected by using restrict fragment length 1 polymorphism polymerase chain reaction(RFLP-PCR) and allele-specific polymerase chain reaction(AS-PCR).Results The frequency of variant genotype on ER-α Intron 1(thymine-cytimidine) in the patients with endometriosis was significantly lower compared with the control group(χ2=10.121,P=0.0060.01).The variant genotype P allele might be a protective factor of EMs.In SNPs of codon 10(thymine-cytimidine) there were no significant differences between the two groups(χ2=0.614,P=0.7360.05).SNPs of intron 1 and codon 10 was not associated with grading of EMs.Conclusion The SNPs of intron 1 of ER-α may be associated with development of endometriosis and the variant P allele of intron 1 of ER-α is a potential protective factor of endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK